Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced the launch of the Thermo Scientific Vulcan™ Automated Lab, a groundbreaking solution ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience. As of fiscal year-end 2024, Thermo ...

Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

Thermo Fisher Scientific Inc. ("Thermo Fisher"), the world leader in serving science, today announced the launch of the Thermo Scientific Vulcantm Automated Lab, a groundbreaking solution designed to ...

The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

WALTHAM, Mass., February 19, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of ...

part of the PPD™ clinical research business of Thermo Fisher Scientific. “High-quality, real-world data can drive much-needed insights on novel treatments and provide hope for patients ...

Its PPD clinical research business plays a key role in advancing diabetes treatments. Thermo Fisher Scientific Inc. (NYSE:TMO) reported strong Q4 2024 results, with revenue of $11.4 billion ...